AbbVie Inc. (LON: 0QCV)
London
· Delayed Price · Currency is GBP · Price in USD 146.95
0.00 (0.00%)
Jul 21, 2022, 7:14 PM BST
AbbVie Revenue
AbbVie had revenue of $14.46B USD in the quarter ending September 30, 2024, with 3.83% growth. This brings the company's revenue in the last twelve months to $55.53B, up 0.72% year-over-year. In the year 2023, AbbVie had annual revenue of $54.32B, down -6.44%.
Revenue (ttm)
$55.53B
Revenue Growth
+0.72%
P/S Ratio
n/a
Revenue / Employee
$1.11M
Employees
50,000
Market Cap
253.76B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | 33.27B | 513.00M | 1.57% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |